Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report

BACKGROUND: Clear cell sarcoma (CCS), initially named malignant melanoma of soft parts, is an aggressive soft tissue sarcoma (STS) that, due to MITF activation, shares with melanoma the expression of melanocyte differentiation antigens. CCS is poorly sensitive to chemotherapy. Multi-kinase inhibitor...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:BMC Cancer
Huvudupphovsmän: Tazzari, Marcella, Palassini, Elena, Vergani, Barbara, Villa, Antonello, Rini, Francesca, Negri, Tiziana, Colombo, Chiara, Crippa, Flavio, Morosi, Carlo, Casali, Paolo G, Pilotti, Silvana, Stacchiotti, Silvia, Rivoltini, Licia, Castelli, Chiara
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2015
Ämnen:
Case Report
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4342079/
https://ncbi.nlm.nih.gov/pubmed/25880253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1044-0
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk